National Health Investors (NYSE:NHI) Hits New 12-Month High – Here’s What Happened

National Health Investors, Inc. (NYSE:NHI)’s stock price hit a new 52-week high during trading on Thursday . The stock traded as high as $82.92 and last traded at $81.44, with a volume of 237914 shares changing hands. The stock had previously closed at $81.12.

Analyst Upgrades and Downgrades

A number of research firms have recently commented on NHI. Deutsche Bank Aktiengesellschaft cut shares of National Health Investors from a “buy” rating to a “hold” rating and set a $85.00 price target on the stock. in a report on Tuesday, January 20th. Wells Fargo & Company upped their price target on National Health Investors from $80.00 to $85.00 and gave the stock an “equal weight” rating in a research report on Tuesday, November 25th. Truist Financial increased their price objective on shares of National Health Investors from $81.00 to $83.00 and gave the company a “buy” rating in a research report on Monday, December 15th. KeyCorp boosted their price objective on shares of National Health Investors from $80.00 to $88.00 and gave the company an “overweight” rating in a report on Thursday, December 4th. Finally, National Bankshares set a $85.00 target price on National Health Investors in a research note on Tuesday, January 20th. One analyst has rated the stock with a Strong Buy rating, four have given a Buy rating and two have issued a Hold rating to the stock. According to MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and an average price target of $85.57.

National Health Investors Price Performance

The firm has a 50-day simple moving average of $78.59 and a two-hundred day simple moving average of $77.01. The company has a market capitalization of $4.01 billion, a price-to-earnings ratio of 26.52, a P/E/G ratio of 2.88 and a beta of 0.66. The company has a current ratio of 10.64, a quick ratio of 10.64 and a debt-to-equity ratio of 0.74.

National Health Investors (NYSE:NHI) last issued its quarterly earnings data on Thursday, November 6th. The real estate investment trust reported $1.32 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.24 by $0.08. The business had revenue of $83.36 million during the quarter, compared to analysts’ expectations of $85.66 million. National Health Investors had a return on equity of 10.17% and a net margin of 41.38%.The company’s revenue for the quarter was down 1.8% on a year-over-year basis. During the same quarter in the previous year, the firm posted $1.03 EPS. As a group, analysts predict that National Health Investors, Inc. will post 4.41 earnings per share for the current fiscal year.

Hedge Funds Weigh In On National Health Investors

Several large investors have recently made changes to their positions in NHI. Vanguard Group Inc. grew its position in National Health Investors by 0.8% during the third quarter. Vanguard Group Inc. now owns 6,498,414 shares of the real estate investment trust’s stock valued at $516,624,000 after buying an additional 52,474 shares during the period. State Street Corp grew its position in shares of National Health Investors by 5.0% during the 2nd quarter. State Street Corp now owns 2,023,381 shares of the real estate investment trust’s stock valued at $143,651,000 after acquiring an additional 95,812 shares during the period. Principal Financial Group Inc. increased its stake in shares of National Health Investors by 1.9% in the 4th quarter. Principal Financial Group Inc. now owns 1,668,006 shares of the real estate investment trust’s stock valued at $127,386,000 after purchasing an additional 30,968 shares in the last quarter. JPMorgan Chase & Co. raised its holdings in National Health Investors by 34.0% in the 3rd quarter. JPMorgan Chase & Co. now owns 1,613,051 shares of the real estate investment trust’s stock worth $128,238,000 after purchasing an additional 409,559 shares during the period. Finally, Geode Capital Management LLC boosted its position in National Health Investors by 4.5% during the second quarter. Geode Capital Management LLC now owns 1,232,524 shares of the real estate investment trust’s stock worth $86,434,000 after purchasing an additional 53,630 shares in the last quarter. 62.51% of the stock is currently owned by institutional investors and hedge funds.

About National Health Investors

National Health Investors, Inc (NYSE: NHI) is a specialized real estate investment trust (REIT) focused on owning and financing high-quality healthcare and senior housing facilities in the United States. The company’s portfolio encompasses a diverse range of properties, including skilled nursing centers, assisted living and memory care communities, behavioral health facilities, dialysis clinics, and medical office buildings. NHI typically enters into long-term net-lease agreements with experienced healthcare operators, providing stable and predictable rental income streams while enabling its tenants to concentrate on delivering quality care.

Since its founding in 1991 and initial public offering later that year, National Health Investors has pursued a disciplined growth strategy centered on strategic acquisitions, joint ventures, and selective development.